Sanofi to buy Brazil's Medley next week-report (Reuters, 3 April 2009)

09 Apr 2009


The French drug company Sanofi-Aventis is rumoured to be planning to buy Brazilian generic drugmaker Medley next week for about $700 million.

Full article


Hormones in the News